White Paper

If 2020 was the year of life science supply chain breakdowns, 2021 is the year of good distribution practices (GDP). The inherent gaps in quality measures that rose to the surface during the COVID-19 pandemic are now being leveraged by manufacturers as lessons learned to pave a more resilient path forward.

Pharmaceutical manufacturers, both large and small, are trying to realize the full potential of process automation, digital, analytics, and big data. The goal is to create a digitally transformed company that connects people, processes, data, technology, and partner organizations together in a connected ecosystem. This white paper explores how to avoid common mistakes and bypass deployment obstacles.

When implementing a digital QMS implementation strategy, there are four necessary steps: Design, Deploy, Control, and Review/Improve. Read more on QMS implementation tips outlined in this white paper.